• 1. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 2. Fe3O4@SiO2 core–shell nanoparticles for biomedical purposes: adverse effects on blood cells?
  C. Achilli,G. F. Guidetti,A. Ciana,D. Capsoni,G. Minetti Biomater. Sci., 2016,4, 1417-1421
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 5. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyrimidines 6-aminopurines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyrimidines Purines and purine derivatives 6-aminopurines

3-Ethyl Adenine-d5 (2% d0): A Comprehensive Guide to Its Properties, Applications, and Market Trends

3-Ethyl Adenine-d5 (2% d0) (CAS No. 147028-85-1) is a deuterated derivative of adenine, a fundamental building block in nucleic acids. This compound has garnered significant attention in the fields of pharmaceutical research, biochemical labeling, and metabolic studies. Its unique isotopic composition makes it an invaluable tool for scientists exploring drug metabolism, pharmacokinetics, and molecular interactions.

The deuterium labeling in 3-Ethyl Adenine-d5 provides distinct advantages in mass spectrometry and NMR spectroscopy, enabling researchers to track molecular pathways with high precision. The 2% d0 component refers to the natural abundance of non-deuterated molecules, which is critical for calibration and quality control in analytical applications. This balance ensures accurate data interpretation while maintaining the compound's stability and reactivity.

One of the most pressing questions in modern research is how to improve the accuracy of drug metabolism studies. 3-Ethyl Adenine-d5 (2% d0) addresses this challenge by serving as an internal standard in LC-MS (Liquid Chromatography-Mass Spectrometry) analyses. Its deuterated structure minimizes interference with endogenous compounds, making it a preferred choice for quantifying adenine derivatives in complex biological matrices.

In the context of personalized medicine, this compound plays a pivotal role. Researchers are increasingly using isotopically labeled compounds like 3-Ethyl Adenine-d5 to develop targeted therapies. For instance, its application in cancer research helps elucidate the metabolic pathways of purine analogs, which are commonly used in chemotherapy. By understanding these pathways, scientists can optimize drug dosages and reduce side effects.

The demand for high-purity biochemical reagents has surged in recent years, driven by advancements in genomics and proteomics. 3-Ethyl Adenine-d5 (2% d0) meets this demand with its exceptional purity and consistency, making it a staple in laboratories worldwide. Its stability under various experimental conditions further enhances its utility in long-term studies.

Another hot topic in scientific circles is the role of stable isotopes in environmental monitoring. While 3-Ethyl Adenine-d5 is primarily used in biomedical research, its principles are being adapted to track pollutants and study ecological systems. This cross-disciplinary applicability underscores its versatility and broad relevance.

From a commercial perspective, the market for deuterated compounds is expanding rapidly. Pharmaceutical companies and contract research organizations (CROs) are investing heavily in isotopic labeling technologies to accelerate drug discovery. 3-Ethyl Adenine-d5 (2% d0) is at the forefront of this trend, with its applications extending to diagnostic assays and biomarker discovery.

Quality control is a critical aspect of producing 3-Ethyl Adenine-d5. Manufacturers adhere to stringent protocols to ensure batch-to-batch consistency, which is vital for reproducible research outcomes. Analytical techniques such as HPLC and GC-MS are employed to verify purity and isotopic enrichment, guaranteeing that the compound meets the highest industry standards.

In summary, 3-Ethyl Adenine-d5 (2% d0) (CAS No. 147028-85-1) is a cornerstone of modern biochemical and pharmaceutical research. Its unique properties, coupled with its wide-ranging applications, make it indispensable for scientists tackling some of the most complex challenges in medicine and environmental science. As research methodologies continue to evolve, the importance of isotopically labeled standards like this compound will only grow, solidifying its place in the future of scientific innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)